Showing results (1271-1280 of 9,924) with videos related to
Sort By:
Pageof 993
Bone Marrow Transplantation|July 5, 2001
Amiodarone and cyclophosphamide: potential for enhanced lung toxicityR Bhagat, T A Sporn, G D Long, et al.Bone Marrow Transplantation|December 26, 2001
Association between high interleukin-6 levels and adverse outcome after autologous haemopoietic stem cell transplantationE M Tegg, A E Griffiths, R M Lowenthal, et al.Bone Marrow Transplantation|December 26, 2001
Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemiaS Kumar, M G Chen, D A Gastineau, et al.Bone Marrow Transplantation|December 26, 2001
Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantationA Tefferi, S Kumar, R C Wolf, et al.Bone Marrow Transplantation|January 10, 2002
Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell graftsK Theilgaard-Mönch, K Raaschou-Jensen, H Palm, et al.Bone Marrow Transplantation|January 10, 2002
CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCRA Schulenburg, T Watkins-Riedel, H T Greinix, et al.Bone Marrow Transplantation|September 18, 2002
The helper T lymphocyte precursor (HTLp) frequency does not predict outcome after HLA-identical sibling donor G-CSF-mobilised peripheral blood stem cell transplantationG Healey, A P SchwarerBone Marrow Transplantation|September 18, 2002
The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantationR Pihusch, E Holler, D Mühlbayer, et al.Bone Marrow Transplantation|September 18, 2002
Partially matched related donor peripheral blood progenitor cell transplantation in paediatric patients adding fludarabine and anti-lymphocyte gamma-globulinM Ortín, R Raj, E Kinning, et al.Bone Marrow Transplantation|August 16, 2002
A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with stem cell transplantationC K Lee, M de Magalhaes-Silverman, M Hayashi, et al.Pageof 993